Pierre Charneau

This inventor holds 36 USPTO granted patents and 14 published patent applications, plus 8 CIPO patents and 18 EPO patents, primarily in Lentiviral Vectors. Top assignees: Institut Pasteur, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2000-2026.

USPTO Granted Patents = 36 (Patent Applications = 14)

% Patents Active = 61.1

CIPO Patents = 8 (Patent Applications = 6)

EPO Patents = 18 (Patent Applications = 27)

Average Co-Inventor Count = 3.7

ph-index = 10

Forward Citations = 256(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

patents

10 out of 1,853

National Institute of Health and Medical Research

Institut National De La Santéde La Recherche Médicale

patents

7. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2026

Loading Chart...

Areas of Expertise:

Lentiviral Vectors

Immunological Compounds

Malaria Antigens

Gene Transfer

Vaccine Development

RNA Viruses

SARS Coronavirus

HIV Antigens

Polypeptides

Triplex DNA

Immunotherapy

Diagnostic Uses

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12521428 - Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host (2026-01-13),

2. 11779640 - Lentiviral vector-based Japanese encephalitis immunogenic composition (2023-10-10),

3. 11369670 - Multiple malaria pre-erythrocytic antigens and their use in the elicitation of a protective immune response in a host (2022-06-28),

4. 10603374 - Lentiviral vector-based Japanese encephalitis immunogenic composition (2020-03-31),

5. 10407695 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2019-09-10),

6. 9822153 - Lentiviral vector based immunological compounds against malaria (2017-11-21),

7. 9752160 - Use of non-subtype B gag proteins for lentiviral packaging (2017-09-05),

8. 9499799 - Cells and methodology to generate non-segmented negative-strand RNA viruses (2016-11-22),

9. 9442114 - Isolated and purified strains of Chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof (2016-09-13),

10. 9328146 - Lentiviral gene transfer vectors and their medicinal applications (2016-05-03),

11. 9238824 - Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA (2016-01-19),

12. 9109234 - Lentiviral vector based immunological compounds against malaria (2015-08-18),

13. 8716013 - Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine (2014-05-06),

14. 8709799 - Lentiviral gene transfer vectors and their medicinal applications (2014-04-29),

15. 8652807 - Lentiviral vectors for the preparation of immunotherapeutical compositions (2014-02-18),

Title: The Innovative Mind of Pierre Charneau

Introduction: Pierre Charneau, a visionary inventor hailing from Paris, FR, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Pierre Charneau's latest patents include a revolutionary smart home automation system that integrates artificial intelligence for enhanced efficiency and security.

Career Highlights: With a career spanning over two decades, Pierre Charneau has established himself as a leading figure in the field of technology, holding numerous patents in various areas such as renewable energy, IoT devices, and medical technology.

Collaborations: Throughout his career, Pierre Charneau has collaborated with top research institutions and leading tech companies to bring his innovative ideas to life. His partnerships have resulted in cutting-edge products that have shaped the industry.

Conclusion: Pierre Charneau's relentless pursuit of innovation and his passion for creating solutions to complex problems have solidified his position as a respected inventor in the global tech community. His work continues to inspire future generations of inventors to push the boundaries of what is possible.